Orthopaedic knee implant price: Proven cap extended to 2027
Orthopaedic knee implant price cap extended until January 2027, ensuring affordability and access for patients needing essential treatments.
Orthopaedic knee implant price cap extended until January 2027, ensuring affordability and access for patients needing essential treatments.
Cevimeline HCl approval marks a significant milestone for Cosette. Discover its implications for the pharma industry.
USFDA approval otic suspension marks a significant milestone for Alembic Pharmaceuticals, enhancing treatment options.
Aurobindo Pharma USFDA approval has sparked a rally, reaching a new 52-week high. Discover what this means for investors.